Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bach‐Yen T. Nguyen"'
Autor:
Nancy Reau, Michael N. Robertson, Hwa‐Ping Feng, Luzelena Caro, Wendy W. Yeh, Bach‐Yen T. Nguyen, Janice Wahl, Eliav Barr, Peggy Hwang, Stephanie O. Klopfer
Publikováno v:
Hepatology Communications, Vol 1, Iss 8, Pp 757-764 (2017)
Concomitant proton pump inhibitor (PPI) use reduces plasma concentrations of certain nonstructural protein 5A inhibitors, which are key components of modern hepatitis C infection (HCV) treatments. These reduced concentrations may decrease efficacy, l
Externí odkaz:
https://doaj.org/article/4c7209c5aab146baa45be70dea5608b3
Autor:
Kathleen E, Squires, Linda-Gail, Bekker, Joseph J, Eron, Benjamin, Cheng, Juergen K, Rockstroh, Farid, Marquez, Princy, Kumar, Melanie, Thompson, Rafael E, Campo, Karam, Mounzer, Kim M, Strohmaier, Chengxing, Lu, Anthony, Rodgers, Beth E, Jackson, Larissa A, Wenning, Michael, Robertson, Bach-Yen T, Nguyen, Peter, Sklar, H, Albrecht
The racial diversity and gender distribution of HIV-infected patients make it essential to confirm the safety and efficacy of raltegravir in these populations. A multicenter, open-label, single-arm observational study was conducted in a diverse cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02d054fa2d0b7091142579223f3458c
Autor:
Bach-Yen T, Nguyen, Robin D, Isaacs, Hedy, Teppler, Randi Y, Leavitt, Peter, Sklar, Marian, Iwamoto, Larissa A, Wenning, Michael D, Miller, Joshua, Chen, Ramon, Kemp, Wei, Xu, Robert A, Fromtling, Joseph P, Vacca, Steven D, Young, Michael, Rowley, Michael W, Lower, Keith M, Gottesdiener, Daria J, Hazuda
Publikováno v:
Annals of the New York Academy of Sciences. 1222
Raltegravir is the first integrase strand transfer inhibitor approved for the treatment of HIV-1 infection. As the first agent in this new class of antiretroviral therapies, raltegravir has demonstrated safety and efficacy in treatment-naive as well